EyePoint, Inc. (EYPT)
2.99
-0.15
(-4.78%)
USD |
NASDAQ |
Oct 16, 16:00
3.09
+0.10
(+3.34%)
After-Hours: 20:00
EyePoint Cash from Operations (Quarterly) : -62.35M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -62.35M |
| March 31, 2026 | -80.55M |
| December 31, 2025 | -65.05M |
| September 30, 2025 | -59.35M |
| June 30, 2025 | -62.59M |
| March 31, 2025 | -53.12M |
| December 31, 2024 | -35.85M |
| September 30, 2024 | -39.03M |
| June 30, 2024 | -20.18M |
| March 31, 2024 | -31.17M |
| December 31, 2023 | -23.11M |
| September 30, 2023 | -15.20M |
| June 30, 2023 | 57.02M |
| March 31, 2023 | -16.84M |
| December 31, 2022 | -12.59M |
| September 30, 2022 | -13.14M |
| June 30, 2022 | -19.12M |
| March 31, 2022 | -20.16M |
| December 31, 2021 | -16.67M |
| September 30, 2021 | -7.787M |
| June 30, 2021 | -10.54M |
| March 31, 2021 | -15.10M |
| December 31, 2020 | 5.895M |
| September 30, 2020 | 1.136M |
| June 30, 2020 | -5.121M |
| Date | Value |
|---|---|
| March 31, 2020 | -16.34M |
| December 31, 2019 | -11.49M |
| September 30, 2019 | -14.77M |
| June 30, 2019 | -17.11M |
| March 31, 2019 | -13.33M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| June 30, 2017 | -4.452M |
| March 31, 2017 | -4.543M |
| December 31, 2016 | -5.009M |
| September 30, 2016 | -6.486M |
| June 30, 2016 | -4.347M |
| March 31, 2016 | -4.302M |
| December 31, 2015 | -3.174M |
| September 30, 2015 | -4.493M |
| June 30, 2015 | -3.006M |
| March 31, 2015 | -3.954M |
| December 31, 2014 | 21.25M |
| September 30, 2014 | -3.994M |
| June 30, 2014 | -2.785M |
| March 31, 2014 | -1.852M |
| December 31, 2013 | -2.257M |
| September 30, 2013 | -3.777M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -67.27M |
| Corcept Therapeutics, Inc. | 33.54M |
| Eli Lilly & Co. | 10.69B |
| Regeneron Pharmaceuticals, Inc. | 813.00M |
| Nuvation Bio, Inc. | -42.97M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 75.10M |
| Cash from Financing (Quarterly) | 19.99M |
| Free Cash Flow | -271.28M |
| Free Cash Flow Per Share (Quarterly) | -0.7343 |
| Free Cash Flow to Equity (Quarterly) | -63.60M |
| Free Cash Flow to Firm (Quarterly) | -63.55M |
| Free Cash Flow Yield | -111.4% |